Vanderbilt Health researchers are enrolling hundreds of adult patients age 65 and older for a study of persons who have not ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study found a 45% reduction in C. diff infections among high-risk patients when the antibiotic doxycycline was used instead ...

In a phase-one human clinical trial, a pharmacist researcher has demonstrated that a new antibiotic, called Omadacycline, may be a promising tool in combating the superbug known as C diff which causes ...

DEAR DR. ROACH: We have a friend hospitalized with C. diff several months ago after working at an assisted-living facility. How do we minimize the risk to our family when this person visits our home?

Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection ...

Most cases of C. diff are treated with oral antibiotics that specifically target the infection, such as vancomycin or fidaxomicin. These medications work by eliminating the C. diff bacteria while ...

Newly discovered iron storage 'ferrosomes' inside the bacterium C. diff -- the leading cause of hospital-acquired infections -- are important for infection in an animal model and could offer new ...

A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk. C. diff infections can be deadly, and ...

Iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — could offer new targets for antibacterial drugs to combat the pathogen. A team of Vanderbilt ...